Retatrutide is hepatically cleared tracking liver enzymes catches stress on the system early
The average amount of weight loss in the treatment group was 15.3kg, as compared to 2.6kg in the placebo group
Retatrutide is an investigational triple agonist acting on GLP-1, GIP, and glucagon receptors, not yet approved by the MHRA or EMA for use in the UK
Ozempic contains semaglutide, the same active ingredient found in Wegovy
Possible side effects Injection site pain, redness, or small swelling Headache, nausea, dizziness, or flushing Skin rashes or hives
By undergoing the Article 28 process and achieving accreditation, Century Medical and Dental Center demonstrates its commitment to meeting the highest standards of care